awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q31060162-9A442494-7660-4A1E-90B5-6DEACA9B0366
Q31060162-9A442494-7660-4A1E-90B5-6DEACA9B0366
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31060162-9A442494-7660-4A1E-90B5-6DEACA9B0366
Effect of angiogenesis inhibitor bevacizumab on survival in patients with cancer: a meta-analysis of the published literature.
P2860
Q31060162-9A442494-7660-4A1E-90B5-6DEACA9B0366
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31060162-9A442494-7660-4A1E-90B5-6DEACA9B0366
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f97088c95f86ca65c3e0f206fa0f8432e4db614a
P2860
Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial.